|
Biobran:
Βιβλιογραφία - Έρευνα - Μελέτες
Κλινικές
μελέτες:
-
J. Markus, A. Miller, M.
Smith, I. Orengo -
Metastatic
Hemangiopericytoma of the Skin Treated with Wide Local Excision and
MGN-3 (Dermatologic Surgery -32-145-147; 2006) (pdf)
-
Yasushi Okamura -
The Clinical Significance of BioBran in the
Immunotherapy of Cancer (Clinical Pharmacology and Therapy Vol. 14/3)
[2004]
-
Hiroshi Tsunekawa -
Effects of Long-term Administration of
Immunomodulatory Food on Cancer Patients Conventional Treatments
(Clinical Pharmacology and Therapy Vol. 14/3) [2004]
-
K. Takahara, K. Sano -
The Life Prolongation and QOL Improvement
Effect of Rice Bran Arabinoxylan Derivative (MGN-3, BioBran) for
Progressive Cancer (Clinical Pharmacology and Therapy Vol. 14/3)
[2004]
-
Kazutoshi Kaketani -A Case Where an Immunomodulatory Food was
Effective in Conservative Therapy for Progressive Terminal Pancreatic
Cancer. (Clinical Pharmacology and Therapy Vol. 14/3) [2004]
-
Kenichi Ichihashi -
Experience with Administration of
BioBran in Patients with Chronic Rheumatism
(Clinical Pharmacology and Therapy Vol. 14/4) [2004]
-
Maeda H, Ichihashi K, Fujii T, Omura K, Zhu X, Anazawa M, Tazawa K
- Oral administration of hydrolyzed rice bran prevents the common cold
syndrome in the elderly based on its immunomodulatory action.
(Biofactors. 2004;21(1-4):185-7).
-
Ghoneum M and Brown J. 1999. NK
Immunorestoration of Cancer Patients by MGN-3, A Modified Arabinoxylan
Rice Bran (Study of 32 patients Followed for up to 4 years)’’,
Anti-Aging Medical Therapeutics
-
Kawai
T. 2004. ‘’One case of a patient with Umbilical
Metastasis of Recurrental Cancer (Sister Mary Joseph’s Nodule, SMJN)
Who Has Survived for a Long Time under Immunomodulatory Supplement
Therapy’’, Clinical Pharmacology and Therapy, Vol.14, No.3,
pp.281-288
------------------------------------------------------------
Εργασίες:
-
Ghoneum M., Drew Univercity.
Enhancement of human natural killer
cell activity by modified Arabinoxylan from rice bran (BioBran
MGN-3). Int. Immunotherapy XIV (2) 89-99, 1998)
-
Ghoneum M, Jewett A.
Production of tumor necrosis factor-alpha and
interferon-gamma from human peripheral blood lymphocytes by MGN-3, a
modified arabinoxylan from rice bran, and its synergy with
interleukin-2 in vitro. Cancer Detection and Prevention 2000;
24(4):314-324
-
M. Ghoneum, M. Matsuura -
Augmentation of macrophage phagocytosis
by modifier arabinoxylan rice bran (MGN-3/BioBran)
(Journal:International Journal of Immunopathology and Pharmacology)
[2004/5/12]
-
M. Ghoneum, S. Abedi -
Enhancement of natural killer cell activity
of aged mice by modified arabioxylan rice bran(MGN-3/Biobran)
(Journal:Journal of Pharmacy and Pharmacology) [2004/5/12]
-
Ghoneum M, Gollapudi S.-Modified arabinoxylan rice bran
(MGN-3/Biobran) sensitizes human T cell leukemia cells to death
receptor (CD95)-induced apoptosis.(Cancer Letters. 2003 Nov
10;201(1):41-9).
-
Ghoneum M, Gollapudi S.
Modified arabinoxylan rice bran
(MGN-3/Biobran) enhances yeast-induced apoptosis in human breast
cancer cells in vitro. (Anticancer Res. 2005 Mar-Apr;25(2A):859-70).
-
M Ghoneum -
Anti-HIV activity in Vitro of MGN-3, an Activated
Arabinoxylan from Rice Bran Biochemical & [Biophysical Research
Communications 243, 25-29 (1998)].
-
Zhong X Lu, Karen Z Walker, Jane G Muir, Tom
Mascara and Kerin O'Dea
Arabinoxylan fiber, a byproduct of wheat flour
processing, reduces the postprandial glucose response in normoglycemic
subjects American Journal of Clinical Nutrition, Vol. 71,
No. 5, 1123-1128, May 2000
-
Ohara
I., Onai K. and Maeda H, 1999. ‘’ Modified Rice
Bran MGN-3, Improves Glucose Tolerance in NIDDM Adult Rats Given
Streptozotocin as Neonats’’ , Journal of the American College
of Nutrition, Vol.18, No.5, Abstract 108,549.
-
Ohara
I., Tabuchi R., and Onai K. 2000 ‘’Effects of
Modified Rice Bran on Serum Lipids and Test Preference in
Streptozotocin-Induced Diabetic Rats’’, Nutrition Research,
Vol.20, No.1, pp59-68
-
Jacoby
H., Wnorowski G., Sakata K., and Maeda H. 2000 ‘’The
Effect of MGN-3 on Cisplatin and Adriamycin Induced Toxicity in the
Rat’’, Gastroenterology, Vol. 118, No.4, 4962.
-
Ghoneum M, Gollapudi S. 2005. ‘’Synergetic Role
of Arabinoxylan Rice Bran (MGN-3/Biobran) in S. cervisiae-induced
Apoptosis of Monolayer Breast Cancer MCF-7 Cells’’. (Anticancer
Res.;25: 4187-4196).
-
Ghoneum M, Gollapudi S.-Modified arabinoxylan
rice bran (MGN-3/Biobran) sensitizes human T cell leukemia cells to
death receptor (CD95)-induced apoptosis.(Cancer Letters.
2003 Nov
10;201(1):41-9).
-
Maeda
H, 1999. ‘’Immunopotentiation Effects of Rice
Bran Arabinoxylan’’ Food Style 21, Vol.3, No.12, pp.56-58
-
Tazawa K.
et al. 2000. ‘’Scavening
activity of MGN-3 (Arabinoxylan from Rice Bran) with Natural Killer
Cell aActivity on Free Radicals’’ Biotherapy, Vol.14, No5, pp.
493-495.
-
Kubo C,
et.
Al.
2001. ‘’The basic study of Arabinoxylan compound
(MGN-3) on the activation of vital defense’’ Clinical and
Research Vol.78, No.1, pp.193-196
-
Maeda
H, 2003. ‘’ The food function of Modified
Arabinoxylan from Rice Bran (MGN-3)’’ Packing of Food, Vol.33,
No.1, pp.45-53
-
Lane Labs -
How to pump up your immune system (Journal:
Alternative Medicine, Jan/Feb 2003) [2003]
-
Ghoneum M, Matsuura M. and
Gollapudi S, ''Modified Arabinoxylan rice
bran (MGN-3BioBran enhances intercellular killing of microbes by human
phagocytic cells in vitro'' International Journal of
Immunopathology & Pharmacology, Vol.21, No.1, pp.87-95
2008
-
Gollapudi S and
Ghoneum M, ''MGN-3Biobran,modified
arabinoxylan from rice bran, sensitizes human breast cancer cells to
chemotherapeutic agent, daunorubicin'' Cancer Detection &
Prevention, 02, CDP 425 1-6, 2008
-
Nariman K. Badr El-Din, Noaman E. and Ghoneum M, ''In
Vivo Tumor Inhibitory Effects of Nutritional Rice Bran Supplement
MGN-3Biobran on Ehrlich Carcinoma-Bearing Mice'' Nutrition &
Cancer,
60(2), 235-244,
2008.
Άλλες δημοσιεύσεις
-
Dr. Hiroo Sanada
Hepatic Impairment Inhibiting Effect of
BioBran Interview (Professor of Department of
Bioproduction Science, Faculty of Horticulture, Chiba University)
-
K. Sriwatanakul,
Arabinoxylan as a Biological Response Modifier (Journal:BioBran
Workshop 2004) [2004/9/26, Oxford]
-
B. Pfeifer,
Phytotherapy for Prostate Cancer -Hope or Reality?-
(Journal:BioBran Workshop 2004) [2004/9/26, Oxford]
-
S. Jurasunas,
Clinical Trial Results of Combination Therapy including BioBran
(Journal:BioBran Workshop 2004) [2004/9/26,
Oxford]
-
M. Ghoneum,
A novel Approach to Cancer Treatment (Journal:A Scientific
Presentation on Immunotherapy) [2004/7/31, Singapore]
-
M. Ghoneum,
Development and Research into Rice Derivative BRM
(Journal:Innovative Industry Initiative (I3) Forum)
[2004/7/29, Bangkok]
-
H. Maeda,
Future Evaluation of Immune-Enhancing Food
(Journal:Cancer Forum
2004) 2004/7/25, Tokyo]
-
M.Koshibu,
Monologue of a Surgeon -A Passion for Supplements (Journal:Cancer
Forum 2004) [2004/7/25, Tokyo
-
New Concepts for the Treatment of Cancer (Journal:Cancer Forum
2004) Autor: M. Ghoneum [2004/7/25, Tokyo]
-
T. Omori,
Clinical Experience in Using Arabinoxylan Compound
(Journal:The
1st South East Asia Symposium on The Role of Biological Response
Modifier (BRM) in Cancer Management) [2004/4/24,
Bangkok]
-
H. Maeda,
Breakthrough Discovery of Arabinoxylan Compound - BioBran
(Journal:The 1st South East Asia Symposium on The Role of Biological
Response Modifier (BRM) in Cancer Management)
[2004/4/24, Bangkok]
-
K.
Sriwatanakul, The Role of Biological Response Modifier (BRM) in Cancer
Management (Journal:The 1st South East Asia Symposium on The Role of
Biological Response Modifier (BRM) in Cancer Management) [2004/4/24, Bangkok]
-
B. Pfeifer,
Phytotherapy for Prostate Cancer Treatment
(Journal:The 1st South
East Asia Symposium on The Role of Biological Response Modifier (BRM)
in Cancer Management) [2004/4/24, Bangkok]
-
T. Omori,
Dual Attack Therapy for Advance Cancer (Journal:The 1st South East
Asia Symposium on The Role of Biological Response Modifier (BRM) in
Cancer Management) [2004/4/24, Bangkok]
-
Y. Endo,
Chairman's remark (Journal:BioBran Workshop 2004)
[2004/9/26, Oxford]
-
H. Maeda,
BioBran Basic Research Update (Journal:BioBran Workshop 2004)
[2004/9/26, Oxford]
-
B. Pfeifer,
Immune Supportive Therapy for Cancer Patients (Journal:The 1st South East Asia Symposium on The Role of Biological Response Modifier
(BRM) in Cancer Management) [2004/4/24, Bangkok]
------------------------------------------------------------
Ακόμη:
Νέο Ερευνητικό Πρωτόκολλο για τον Καρκίνο του
Προστάτη
|